---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-006274"
form_type: "8-K"
ticker: "PMCB"
cik: "0001157075"
company_name: "PharmaCyte Biotech, Inc."
filed_at: "2025-08-18T23:59:59+00:00"
generated_at: "2026-05-17T11:48:22.676515+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# PharmaCyte raises $7M in private placement of Series C convertible preferred and warrants

## Summary
- Sale of 7,000 shares of Series C preferred (stated value $1,000) convertible into 7M common at $1.00 per share.
- Warrants to purchase 7M common shares at $1.00, exercisable immediately for 5 years.
- Preferred shares accrue a 7% quarterly dividend payable in cash; 15% upon trigger event.
- Company must seek stockholder approval by Oct 31, 2025 to issue >19.99% of outstanding common.
- Proceeds used for general corporate purposes and working capital; closing expected Aug 19, 2025.

## SEC filing metadata
- accession: 0001683168-25-006274
- form_type: 8-K
- ticker: PMCB
- cik: 0001157075
- company_name: PharmaCyte Biotech, Inc.
- filed_at: 2025-08-18T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1157075/000168316825006274/0001683168-25-006274-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1157075/000168316825006274/pharmacyte_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-006274
- JSON: https://secwatch.observer/filing/0001683168-25-006274.json
- Plain text: https://secwatch.observer/filing/0001683168-25-006274.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.